Professional Documents
Culture Documents
O O
N–C–C–N–C–C N–C–C–N–C–C
R H R’
O-
C
Ser
Specificity
Site Catalytic Site
Active Site
O O
O O O O
–C–N–C–C–N–
–C–N–C–C–N– –C–N–C–C–N–
C
C
C CH3
C
Deep and negatively
C
charged pocket
Shallow and
non-polar
NH3 pocket
+
Active Site
Stereo Specificity
A
sp3
D
B D C
Enzyme surface C B B
The tetrahedral structure C D
of carbon orbital has rigid
steric strain which makes
the basic building unit of These two triangles are
protein conformation
not identical
Juang RH (2004) BCbasics
Chiral fine chemicals, $ 16
billion 2007
]
N CH 2 Asetil kholin
CH2 CH2
GUGUS SERINE
O
_
+ OH
+ Diisopropilfluorofosfat
H2O
F (DIFP)
Asetil kholin esterase CH3 CH3
CH O P O CH
CH3 CH3
O
-
CH2 COO Asetil
+ kholin
HF
CH2
+ E
HO CH2 CH2 N CH2
CH2
CH2
DIFP : inhibit serine enzyme CH3 O
CH3
CH O P O CH
CH3 CH 3
O
Covalent immobilization of trypsin
on cotton bandage for future use
as an anti-inflammatory agent on
wound dressing.
Protease inhibitors are important drugs
Benazepri)
Captopril
Enalapril
Fosinopril
Lisinopril
Diuretics
\Vitamin
Contain K
ACE in
several
tissues
Angiotensin-I:
NH2-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe♦His-Leu-COOH
Angiotensin-II:
NH2-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-COOH
Lineweaver-
BurkInhibitor
Figure 8.1: Lineweaver-Burk plot of initial reaction rates of engineered ACE plot Vand of
engineered
Natural ACE Inhibitor Peptide, showing the relationship to be non-competitive ACE
inhibition
Inhibitor and
Natural ACE
Inhibitor
Peptide,
showing the
relationship to
be non-
competitive
inhibition.
2001 Journal of Biological Chemistry,
276
A inhibition of PfCK with 0, 0.5 & 1mM T3; (B) inhibition of PfEK. the apparent Km (Km′)
plotted as function of inhibitor concentration. Ki values were obtained by intercept with
the x-axis as indicated by the arrow (-Ki)
Enzyme structure and mechanism
Serine
• Amino acid
• alcohol as residue
Serine Protease
• Cutting certain peptide
bonds in other proteins
• Based on nucleophilic
attack of the targeted
peptidic bond by a serine
Digestive enzymes
• Pancreatic proteases
proenzymes trypsinogen and chymotrypsinogen
synthesized in the pancreas and secreted into
the lumen of the small intestine
Mechanism
Active site
Chymotrypsin Has A Site for Specificity
O O
N–C–C–N–C–C N–C–C–N–C–C
R H R’
O-
C
Ser
Specificity
Site Catalytic Site
Active Site
O O
O O O O
–C–N–C–C–N–
–C–N–C–C–N– –C–N–C–C–N–
C
C
C CH3
C
Deep and negatively
C
charged pocket
Shallow and
non-polar
NH3 pocket
+
Active Site
Trypsinogen-Trypsin
• loss of six amino acids from one end
• overall structures remain similar
• Ca++ for thermal stability
activated enzyme
does have more of its
structure organized
into sheets
Chymotrypsin
• Active site: His57-Ser195-Asp102
Water substitutes
for the amine
component.
-OH attacks the
C=O
Transient
tetrahedral
intermediate
His 57 donates an
H, acid
component is
released
Enzyme is ready for
another
catalysis
Catalytic triad
Why is chymo specific?
• Where does its specificity for cleaving only phe, trp, and tyr
come from?
Catalytic Triad
His57
Asp102 Ser195
H H
O
[HOOC] C N C C [NH2]
N C H C N C
C
O
His57
Asp102 Ser195
H H
O
C C [NH2]
C N
[HOOC] C N C
N C H C
O
H O
H
C C
C [NH2 ]
C N C N
[HOOC] C
N C H O
Acyl-Enzyme Intermediate
Chymotrypsin Catalytic Mechanism D1
H O
H O
C C
H
C [NH2 ]
C N C
O
C N-H
[HOOC]
N C H
H
O
C C
O C [NH2 ]
H C N C
O
H
H O
O C C [NH2]
H C N C
C
O
Deacylation
Multiple form of enzyme
Aspartate aminotransferase
Glucose-6-phosphate dehydrogenase
Lactate dehydrogenase
Malate dehydrogenase
Time Course of Myocardial Enzyme
Elevations in Serum after Infarction
#3 control specimen method
#8 normal specimen.
# 1 MI patient. LDH and CK elevated Note
# 2 MI patient with previous chest pain
# 4 liver disease
# 5 MI patient; 2 days post MI CK has
almost returned to normal activity and LDH
flip is definite.
# 6 MI patient 1st day post MI; CK elevated
# 7 MI patient complications of heart
failure and passive liver congestion
Change in total superoxide dismutase activity and its isozyme patterns during cotyledon
senescence. DAP = Days after planting
(A)Total SOD activity. Sample weight was 0.5 g per time point
(B) SOD isoforms. 30 μg protein per load . W1, W2, W3 and W4 wild type (WT)
cotyledon at 10, 20, 30 and 40 DAP respectively M1, M2, M3 and M4 mutant type (MT)
cotyledon at 10, 20, 30 and 40 DAP
(C) Different isoforms of SOD using inhibitors. preincubation 5 mM H2O2 or 3 mM KCN.